{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,12]],"date-time":"2026-09-12T20:07:40Z","timestamp":1789243660834,"version":"build-2803163510"},"reference-count":38,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,7,22]],"date-time":"2026-07-22T00:00:00Z","timestamp":1784678400000},"content-version":"vor","delay-in-days":21,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82460372"],"award-info":[{"award-number":["82460372"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Pharmacology"],"published-print":{"date-parts":[[2026,7]]},"DOI":"10.1016\/j.ejphar.2026.179038","type":"journal-article","created":{"date-parts":[[2026,6,4]],"date-time":"2026-06-04T16:19:15Z","timestamp":1780589955000},"page":"179038","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Survival benefit analysis of beta-blockers in patients with sepsis-induced TnT-positive myocardial injury across different clinical subtypes of sepsis: A retrospective study based on the MIMIC-IV database"],"prefix":"10.1016","volume":"1030","author":[{"given":"Wen","family":"Guo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Long","family":"Ma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yi","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0007-3510-3105","authenticated-orcid":false,"given":"Xiaoming","family":"Gao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Li","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qindan","family":"Qin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiang","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3834-758X","authenticated-orcid":false,"given":"Mangsuer","family":"Nuermaimaiti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2252-0472","authenticated-orcid":false,"given":"Xiangyou","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejphar.2026.179038_bib1","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1097\/CCM.0000000000002851","article-title":"Septic cardiomyopathy","volume":"46","author":"Beesley","year":"2018","journal-title":"Crit. Care Med."},{"key":"10.1016\/j.ejphar.2026.179038_bib2","doi-asserted-by":"crossref","first-page":"4275","DOI":"10.2147\/JIR.S374117","article-title":"Research progress on the mechanism of sepsis induced myocardial injury","volume":"15","author":"Bi","year":"2022","journal-title":"J. Inflamm. Res."},{"key":"10.1016\/j.ejphar.2026.179038_bib3","article-title":"Sepsis pathogenesis and outcome are shaped by the balance between the transcriptional states of systemic inflammation and antimicrobial response","volume":"5","author":"Brandes-Leibovitz","year":"2024","journal-title":"Cell Rep. Med."},{"key":"10.1016\/j.ejphar.2026.179038_bib4","first-page":"391","article-title":"A critical review of the use of carvedilol in ischemic heart disease","volume":"12","author":"Chen-Scarabelli","year":"2012","journal-title":"Am. J. Cardiovasc. Drugs"},{"key":"10.1016\/j.ejphar.2026.179038_bib5","first-page":"e527","article-title":"Systemic inflammation and sepsis. Part I: storm formation","volume":"118","author":"Dartiguelongue","year":"2020","journal-title":"Arch. Argent. Pediatr."},{"key":"10.1016\/j.ejphar.2026.179038_bib6","doi-asserted-by":"crossref","DOI":"10.1016\/j.jclinane.2024.111597","article-title":"Aspirin is associated with improved outcomes in patients with sepsis-induced myocardial injury: an analysis of the MIMIC-IV database","volume":"99","author":"Dong","year":"2024","journal-title":"J. Clin. Anesth."},{"key":"10.1016\/j.ejphar.2026.179038_bib7","doi-asserted-by":"crossref","DOI":"10.3390\/ijms25158058","article-title":"Beta-blockers as an immunologic and autonomic manipulator in critically ill patients: a review of the recent literature","volume":"25","author":"Eraky","year":"2024","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.ejphar.2026.179038_bib8","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1016\/j.jgar.2017.06.013","article-title":"Sepsis and septic shock: new definitions, new diagnostic and therapeutic approaches","volume":"10","author":"Esposito","year":"2017","journal-title":"J. Glob. Antimicrob. Resist."},{"key":"10.1016\/j.ejphar.2026.179038_bib9","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1186\/s44158-023-00126-2","article-title":"The role of beta-blocker drugs in critically ill patients: a SIAARTI expert consensus statement","volume":"3","author":"Guarracino","year":"2023","journal-title":"J. Anesth. Analg. Crit. Care"},{"key":"10.1016\/j.ejphar.2026.179038_bib10","article-title":"Prognostic analysis of sepsis-induced myocardial injury patients using propensity score matching and doubly robust analysis with machine learning-based risk prediction model development","volume":"12","author":"Guo","year":"2025","journal-title":"Front. Med."},{"key":"10.1016\/j.ejphar.2026.179038_bib11","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1007\/s00395-016-0599-5","article-title":"MD2 mediates angiotensin II-induced cardiac inflammation and remodeling via directly binding to Ang II and activating TLR4\/NF-\u03baB signaling pathway","volume":"112","author":"Han","year":"2017","journal-title":"Basic Res. Cardiol."},{"key":"10.1016\/j.ejphar.2026.179038_bib12","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1186\/s40560-021-00552-w","article-title":"\u03b21-blocker in sepsis","volume":"9","author":"Hasegawa","year":"2021","journal-title":"J. Intensiv. Care"},{"key":"10.1016\/j.ejphar.2026.179038_bib13","doi-asserted-by":"crossref","first-page":"1994","DOI":"10.1080\/07853890.2022.2098376","article-title":"Beta-blocker treatment in the critically ill: a systematic review and meta-analysis","volume":"54","author":"Heliste","year":"2022","journal-title":"Ann. Med."},{"key":"10.1016\/j.ejphar.2026.179038_bib14","article-title":"Effect of ultrashort-acting \u03b2-blockers on 28-day mortality in patients with sepsis with persistent tachycardia despite initial resuscitation: a meta-analysis of randomized controlled trials and trial sequential analysis","volume":"15","author":"Huang","year":"2024","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.ejphar.2026.179038_bib15","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41597-022-01899-x","article-title":"MIMIC-IV, a freely accessible electronic health record dataset","volume":"10","author":"Johnson","year":"2023","journal-title":"Sci. Data"},{"key":"10.1016\/j.ejphar.2026.179038_bib16","doi-asserted-by":"crossref","first-page":"1649","DOI":"10.1097\/CCM.0b013e31819def97","article-title":"The sequential organ failure assessment score for predicting outcome in patients with severe sepsis and evidence of hypoperfusion at the time of emergency department presentation","volume":"37","author":"Jones","year":"2009","journal-title":"Crit. Care Med."},{"key":"10.1016\/j.ejphar.2026.179038_bib17","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1186\/s40560-016-0148-1","article-title":"Sepsis-induced myocardial dysfunction: pathophysiology and management","volume":"4","author":"Kakihana","year":"2016","journal-title":"J. Intensiv. Care"},{"key":"10.1016\/j.ejphar.2026.179038_bib18","doi-asserted-by":"crossref","first-page":"e332","DOI":"10.1097\/CCM.0000000000001078","article-title":"\u03b21-Adrenergic inhibition improves cardiac and vascular function in experimental septic shock","volume":"43","author":"Kimmoun","year":"2015","journal-title":"Crit. Care Med."},{"key":"10.1016\/j.ejphar.2026.179038_bib19","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1186\/s40560-021-00553-9","article-title":"Premorbid \u03b21-selective (but not non-selective) \u03b2-blocker exposure reduces intensive care unit mortality among septic patients","volume":"9","author":"Kuo","year":"2021","journal-title":"J. Intensiv. Care"},{"key":"10.1016\/j.ejphar.2026.179038_bib20","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1007\/s11886-020-01277-2","article-title":"Sepsis-induced cardiomyopathy: a comprehensive review","volume":"22","author":"L'heureux","year":"2020","journal-title":"Curr. Cardiol. Rep."},{"key":"10.1016\/j.ejphar.2026.179038_bib21","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1016\/j.jointm.2022.01.004","article-title":"Beta-blockers in septic shock: what is new?","volume":"2","author":"Lescroart","year":"2022","journal-title":"J. Intensive Med."},{"key":"10.1016\/j.ejphar.2026.179038_bib22","doi-asserted-by":"crossref","DOI":"10.1016\/j.cyto.2019.154916","article-title":"Prognosis of \u03b2-adrenergic blockade therapy on septic shock and sepsis: a systematic review and meta-analysis of randomized controlled studies","volume":"126","author":"Li","year":"2020","journal-title":"Cytokine"},{"key":"10.1016\/j.ejphar.2026.179038_bib23","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1016\/j.repc.2021.05.020","article-title":"Septic cardiomyopathy: a narrative review","volume":"42","author":"Lima","year":"2023","journal-title":"Rev. Port. Cardiol."},{"key":"10.1016\/j.ejphar.2026.179038_bib24","first-page":"193","article-title":"[\u03b21 receptor blocker decreases the myocardial inflammation in the sepsis adult rats through inhibition of TLR4\/NF-\u039aB signaling pathway]","volume":"31","author":"Liu","year":"2019","journal-title":"Zhonghua Wei Zhong Bing Ji Jiu Yi Xue"},{"key":"10.1016\/j.ejphar.2026.179038_bib25","doi-asserted-by":"crossref","DOI":"10.1016\/j.eclinm.2020.100571","article-title":"Impact of patient characteristics on the efficacy and safety of landiolol in patients with sepsis-related tachyarrhythmia: subanalysis of the J-Land 3S randomised controlled study","volume":"28","author":"Matsuda","year":"2020","journal-title":"EClinicalMedicine"},{"key":"10.1016\/j.ejphar.2026.179038_bib26","first-page":"809","article-title":"[Prognostic risk factors of patients with sepsis and the clinical characteristics of patients with septic myocardial injury]","volume":"33","author":"Mu","year":"2021","journal-title":"Zhonghua Wei Zhong Bing Ji Jiu Yi Xue"},{"key":"10.1016\/j.ejphar.2026.179038_bib27","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-018-31034-z","article-title":"Alteration of \u03b2-Adrenoceptor signaling in left ventricle of acute phase takotsubo syndrome: a human study","volume":"8","author":"Nakano","year":"2018","journal-title":"Sci. Rep."},{"key":"10.1016\/j.ejphar.2026.179038_bib28","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1080\/03007995.2024.2317443","article-title":"The clinical value of \u03b2-blockers in patients with stable angina","volume":"40","author":"Palatini","year":"2024","journal-title":"Curr. Med. Res. Opin."},{"key":"10.1016\/j.ejphar.2026.179038_bib29","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1016\/S0140-6736(19)32989-7","article-title":"Global, regional, and national sepsis incidence and mortality, 1990-2017: analysis for the global burden of disease study","volume":"395","author":"Rudd","year":"2020","journal-title":"Lancet"},{"issue":"Suppl. 1","key":"10.1016\/j.ejphar.2026.179038_bib30","doi-asserted-by":"crossref","first-page":"S5","DOI":"10.1097\/00005344-199219001-00003","article-title":"Vasodilatory action of carvedilol","volume":"19","author":"Sponer","year":"1992","journal-title":"J. Cardiovasc. Pharmacol."},{"key":"10.1016\/j.ejphar.2026.179038_bib31","first-page":"67","article-title":"Sepsis definition: what's new in the treatment guidelines","volume":"61","author":"Srzi\u0107","year":"2022","journal-title":"Acta Clin. Croat."},{"key":"10.1016\/j.ejphar.2026.179038_bib32","doi-asserted-by":"crossref","DOI":"10.3389\/fcvm.2025.1531711","article-title":"Impact of \u03b2-blockers on mortality in critically Ill patients with type 2 myocardial infarction: insights from a retrospective cohort study","volume":"12","author":"Tang","year":"2025","journal-title":"Front. Cardiovasc. Med."},{"key":"10.1016\/j.ejphar.2026.179038_bib33","first-page":"787","article-title":"[Beta-blockers in Septic Shock]","volume":"53","author":"Uhlig","year":"2018","journal-title":"Anasthesiol. Intensivmed. Notfallmed. Schmerzther"},{"key":"10.1016\/j.ejphar.2026.179038_bib34","doi-asserted-by":"crossref","DOI":"10.1016\/j.redox.2023.102937","article-title":"Cardiomyocyte NOX4 regulates resident macrophage-mediated inflammation and diastolic dysfunction in stress cardiomyopathy","volume":"67","author":"Vendrov","year":"2023","journal-title":"Redox Biol."},{"key":"10.1016\/j.ejphar.2026.179038_bib35","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1002\/jcp.30527","article-title":"Pathogenetic mechanisms of septic cardiomyopathy","volume":"237","author":"Wang","year":"2022","journal-title":"J. Cell. Physiol."},{"key":"10.1016\/j.ejphar.2026.179038_bib36","article-title":"Blood pressure lowering efficacy of dual alpha and beta blockers for primary hypertension","volume":"2015","author":"Wong","year":"2015","journal-title":"Cochrane Database Syst. Rev."},{"key":"10.1016\/j.ejphar.2026.179038_bib37","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1186\/s12871-023-02189-8","article-title":"Predictors and nomogram of in-hospital mortality in sepsis-induced myocardial injury: a retrospective cohort study","volume":"23","author":"Xu","year":"2023","journal-title":"BMC Anesthesiol."},{"key":"10.1016\/j.ejphar.2026.179038_bib38","doi-asserted-by":"crossref","first-page":"3478","DOI":"10.7150\/ijbs.111288","article-title":"Pathogenesis and treatment strategies of sepsis-induced myocardial injury: modern and traditional medical perspectives","volume":"21","author":"Yang","year":"2025","journal-title":"Int. J. Biol. Sci."}],"container-title":["European Journal of Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014299926005200?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014299926005200?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,9,12]],"date-time":"2026-09-12T19:53:29Z","timestamp":1789242809000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0014299926005200"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7]]},"references-count":38,"alternative-id":["S0014299926005200"],"URL":"https:\/\/doi.org\/10.1016\/j.ejphar.2026.179038","relation":{},"ISSN":["0014-2999"],"issn-type":[{"value":"0014-2999","type":"print"}],"subject":[],"published":{"date-parts":[[2026,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Survival benefit analysis of beta-blockers in patients with sepsis-induced TnT-positive myocardial injury across different clinical subtypes of sepsis: A retrospective study based on the MIMIC-IV database","name":"articletitle","label":"Article Title"},{"value":"European Journal of Pharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejphar.2026.179038","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"179038"}}